Hong Kong Pharmaceuticals & Biotech Upcoming Dividends

Tong Ren Tang Technologies

Market Cap: HK$4.1b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.6b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

Pak Fah Yeow International

Market Cap: HK$741.7m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

Jacobson Pharma

Market Cap: HK$2.1b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

Jilin Province Huinan Changlong Bio-pharmacy

Market Cap: HK$1.3b

Manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China.

JBM (Healthcare)

Market Cap: HK$1.6b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally.

Sino Biopharmaceutical

Market Cap: HK$78.6b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

CSPC Pharmaceutical Group

Market Cap: HK$79.7b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$26.6b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.